Results 71 to 80 of about 27,956 (253)

Physical Limitations of Scleroderma- A Personal Perspective

open access: yesAcademic Medicine & Surgery
Scleroderma, like many misunderstood chronic diseases, put a tremendous burden on both the patient and their family. In this deeply personal narrative, the first author describes the impact of scleroderma on her family.
Reema Adusumilli, Sydney Vaughn
openaire   +1 more source

Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Interstitial lung disease (ILD) is an important extra‐articular manifestation of rheumatoid arthritis (RA) associated with high mortality and morbidity. Lung ultrasonography (LUS) has recently emerged as a possible screening tool. We assessed the role of LUS in monitoring radiologic progression and the development of new interstitial lung ...
Marie Vermant   +15 more
wiley   +1 more source

Optimization of Scleroderma spore inoculum for Eucalyptus nurseries in China

open access: yes, 2006
Scleroderma, a genus of ectomycorrhizal (ECM) fungi, is often associated with trees in disturbed habitats and is therefore considered to be suitable for use in plantation forestry.
Chen, Yinglong
core  

Treatment of scleroderma by TCM

open access: yes, 2010
Scleroderma is a rare persistent hardening and contraction of the body’s connective tissue, which often affect any organ, including the skin, heart, kidney, lung or oesophageal.
Yang Xiang (35912)
core   +1 more source

Collalysin in therapy of patients with limited scleroderma

open access: yesKazan medical journal, 1986
In the pathogenesis of scleroderma an essential role is played by intensive collagen biosynthesis, which causes the development of fibrotic-sclerotic lesions. In this connection, it is pathogenetically substantiated the use of agents, the effect of which is aimed at decreasing the synthesis and increasing the catabolism of collagen.
openaire   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo   +7 more
wiley   +1 more source

Scleroderma.

open access: yes, 2009
Scleroderma (systemic sclerosis) is a complex disease in which extensive fibrosis, vascular alterations, and autoantibodies against various cellular antigens are among the principal features There are two major subgroups in the commonly accepted ...
Gabrielli A.   +4 more
core  

Dental implants and scleroderma

open access: yes, 2023
Scleroderma or systemic sclerosis is an autoimmune multisystem rheumatic ailment that impacts on connective tissues.this condition is characterized by fibrosis of the skin and can develop in the heart, lungs, kidneys, and gastrointestinal tract.(https ...
yasaman salimi, Seyed Ali Mosaddad
core   +1 more source

Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome

open access: yesEuropean Journal of Rheumatology, 2019
Abstract Cite this article as: Düzgün N. Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome. Eur J Rheumatol 2017; 4: 305-6.
openaire   +2 more sources

Home - About - Disclaimer - Privacy